Publicaciones en colaboración con investigadores/as de Oslo University Hospital (12)

2024

  1. Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps

    United European Gastroenterology Journal

2023

  1. Macular hole Delphi consensus statement (MHOST)

    Acta Ophthalmologica, Vol. 101, Núm. 7, pp. 815-825

  2. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: Results from the EPoS trials

    Gut, Vol. 72, Núm. 5, pp. 951-957

  3. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 5, pp. 465-476

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2020

  1. Principles for Evaluation of Surveillance After Removal of Colorectal Polyps: Recommendations From the World Endoscopy Organization

    Gastroenterology

2019

  1. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 20, Núm. 6, pp. 781-794

2018

  1. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2016

  1. Estimated GFR and the Effect of Intensive Blood Pressure Lowering after Acute Intracerebral Hemorrhage

    American Journal of Kidney Diseases, Vol. 68, Núm. 1, pp. 94-102

2014

  1. A new non-expressed allele HLA-A*03:168N, identified by serological and sequence-based typing in a voluntary Norwegian hematopoietic stem cell donor

    Tissue Antigens, Vol. 83, Núm. 3, pp. 195-196

2008

  1. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: A randomized trial

    Journal of the National Cancer Institute, Vol. 100, Núm. 8, pp. 533-541